References
- Tavares I, Oliveira JP, Pinho A, et al. Unrecognized fibrinogen a α-chain amyloidosis: results from targeted genetic testing. Am J Kidney Dis. 2017;70:235–243.
- Schifter S. Circulating concentrations of calcitonin gene-related peptide (CGRP) in normal man determined with a new, highly sensitive radioimmunoassay. Peptides. 1991;12:365–369.
- Yazaki M, Yoshinaga T, Sekijima Y, et al. The first pure form of Ostertag-type amyloidosis in Japan: a sporadic case of hereditary fibrinogen Aalpha-chain amyloidosis associated with a novel frameshift variant. Amyloid. 2015;22:142–144.
- Uemichi T, Liepnieks JJ, Alexander F, et al. The molecular basis of renal amyloidosis in Irish-American and Polish-Canadian kindreds. Q J Med. 1996;89:745–750.
- de Carvalho M, Linke RP, Domingos F, et al. Mutant fibrinogen A-alpha-chain associated with hereditary renal amyloidosis and peripheral neuropathy. Amyloid. 2004;11:200–207.
- Alves IL, Almeida MR, Skare J, et al. Amyloidogenic and non-amyloidogenic transthyretin Asn 90 variants. Clin Genet. 1992;42:27–30.
- Pitkänen P, Westermark P, Cornwell GGIII, et al. Amyloid of the seminal vesicles. A distinctive and common localized form of senile amyloidosis. Am J Pathol. 1983;110:64–69.
- Gillmore JD, Booth DR, Rela M, et al. Curative hepatorenal transplantation in systemic amyloidosis caused by the Glu526Val fibrinogen alpha-chain variant in an English family. Q J Med. 2000;93:269–275.